{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:22:28Z","timestamp":1788175348692,"version":"build-2803163510"},"reference-count":24,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>Background: Bone cancer pain (BCP) represents a debilitating complication that profoundly impacts patient quality of life and predisposes to psychological comorbidities, including depression and anxiety. Objectives: To investigate the effect of fumaric acid on morphine tolerance in BCP via spinal MrgC receptors. Methods: This study adopted an in-vivo animal experiment design. The BCP mouse model was established and divided into the Vehicle group, the fumaric acid monotherapy group with different doses, the fumaric acid + morphine combination group, the normal saline + morphine control group and the fumaric acid + normal saline control group. Intervention is carried out through intrathecal administration. Pain behavior tests such as the threshold for mechanical foot retraction, the number of spontaneous foot lifts, the duration of foot lift protection and the latency period of cold pain foot retraction were evaluated. The expression level of MrgC protein in spinal cord tissue was detected by Western blotting and immunohistochemistry. Results: Fumaric acid dose-dependently attenuated BCP and delayed morphine tolerance, with EC?? values of 69.18 mg\/kg (mechanical) and 99.78 mg\/kg (cold). Its effects correlated with downregulation of spinal MrgC expression. Conclusion: Fumaric acid alleviates BCP and delays morphine tolerance by down-regulating the expression of spinal MrgC receptors. MrgC receptors are potential new therapeutic targets.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.8.233.1","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:03:57Z","timestamp":1781010237000},"source":"Crossref","is-referenced-by-count":0,"title":["Fumaric Acid Regulates Morphine Tolerance In Bone Cancer Pain Through Spinal MrgC Receptor Modulation"],"prefix":"10.36721","author":[{"given":"Sijie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Ahmadi S, Majidi M, Koraei M and Vasef S (2024). The inflammation\/NF-\u03baB and BDNF\/TrkB\/CREB pathways in the cerebellum are implicated in the changes in spatial working memory after both morphine dependence and withdrawal in rat. Mol Neurobiol., 61(9): 6721\u20136733.","DOI":"10.1007\/s12035-024-03993-0"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Baldea I, Moldovan R, Nagy AL, Bolfa P, Decea R, Miclaus MO, Lung I, Gherman AMR, Sevastre-Berghian A, Martin FA, Kacso I and R\u0103zniceanu V (2024). Ketoconazole-Fumaric acid pharmaceutical cocrystal: From formulation design for bioavailability improvement to biocompatibility testing and antifungal efficacy evaluation. Int J Mol Sci., 25(24): 13346.","DOI":"10.3390\/ijms252413346"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Chen X, Zeng Y, Wang Z, Zhu J, Liu F, Zhu M, Zheng J, Chen Q, Zhai D, Chen Y, Niu J, Xue Z, Sun G, Li F, Pan Z (2025). NFAT1 signaling contributes to bone cancer pain by regulating IL-18 expression in spinal microglia. CNS Neurosci Ther., 31(2):e70222.","DOI":"10.1111\/cns.70222"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Chen Y, Luo Z, Sun Y, Li F, Han Z, Qi B, Lin J, Lin WW, Yao M, Kang X, Huang J, Sun, C, Ying C, Guo C, Xu Y, Chen J and Chen S (2022). Exercise improves choroid plexus epithelial cells metabolism to prevent glial cell-associated neurodegeneration. Front Pharmacol., 13: 1010785.","DOI":"10.3389\/fphar.2022.1010785"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dash PP, Mohanty P, Behura R, Behera S, Naik S, Mishra M, Sahoo H, Barick AK, Mohapatra P, Sahoo SK and Jali BR (2024). Rapid colorimetric and fluorometric discrimination of maleic acid vs. fumaric acid and detection of maleic acid in food additives. J Fluoresc., 34(3): 1015\u20131024.","DOI":"10.1007\/s10895-023-03330-z"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Erler K, Krafczyk N, Steinbrenner H and Klotz LO (2024). Selective activation of cellular stress response pathways by fumaric acid esters. FEBS Open Bio., 14(8): 1230\u20131246.","DOI":"10.1002\/2211-5463.13833"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Huang Q, Ford NC, Gao X, Chen Z, Guo R, Raja SN, Guan Y and He S (2021). Ubiquitin-mediated receptor degradation contributes to development of tolerance to MrgC agonist-induced pain inhibition in neuropathic rats. Pain., 162(4): 1082\u20131094.","DOI":"10.1097\/j.pain.0000000000002119"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Khalaf MM, Mahmoud HM, Kandeil MA, Mahmoud HA and Salama AA (2024). Fumaric acid protects rats from ciprofloxacin-provoked depression through modulating TLR4, Nrf-2 and p190-rho GTP. Drug Chem Toxicol., 47(6): 897\u2013908.","DOI":"10.1080\/01480545.2024.2310641"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Krefting F, H\u00f6lsken S, Schedlowski M and Sondermann W (2024). Discontinuation of fumaric acid esters is affected by depressive symptomatology: A retrospective analysis. Acta Derm Venereol., 104: 12326.","DOI":"10.2340\/actadv.v104.12326"},{"key":"ref9","unstructured":"Jiang JP, Zhang K, Hu FJ and Hong YG (2024). Mas-related gene C (MrgC) receptor activation induced inhibition of neurochemical alterations in the spinal dorsal horn and dorsal root ganglia in a rat model of bone cancer pain. Sheng Li Xue Bao., 76(6): 953\u2013969."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Li S, Tang S, Dai L, Jian Z and Li X (2024). Emodin relieves morphine-stimulated BV2 microglial activation and inflammation through the TLR4\/NF-\u03baB\/NLRP3 pathway. Neuroreport., 35(8): 518\u2013528.","DOI":"10.1097\/WNR.0000000000002034"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lipina TV, Giang H, Thacker JS, Wetsel WC, Caron MG, Beaulieu JM, Salahpour A and Ramsey AJ (2024). Combination of haloperidol with UNC9994, \u03b2-arrestin-biased analog of aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in mice. Int J Neuropsychopharmacol., 27(12): pyae060.","DOI":"10.1093\/ijnp\/pyae060"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ni C, Chen L, Hua B, Han Z, Xu L, Zhou Q, Yao M and Ni H (2024). Epigenetic mechanisms of bone cancer pain. Neuropharmacology., 261: 110164.","DOI":"10.1016\/j.neuropharm.2024.110164"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Patyk-Ka\u017amierczak E and Ka\u017amierczak M (2024). Metal-free negative linear compressibility (NLC) material - the cocrystal of 1, 2-bis(4-pyridyl)ethane and fumaric acid. Chem Commun (Camb)., 60(75): 10310\u201310313.","DOI":"10.1039\/D4CC02183E"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Shao X, Xie L, Zhai J and Ge M (2024). Postoperative analgesia with morphine promoting microglial activation and neuroinflammation induced by surgery aggravates perioperative neurocognitive dysfunction in aged mice. IBRO Neurosci Rep., 18: 39\u201349.","DOI":"10.1016\/j.ibneur.2024.12.008"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Underwood O, Fritzwanker S, Glenn J, Blum NK, Batista-Gondin A, Drube J, Hoffmann C, Briddon SJ, Schulz S and Canals M (2024). Key phosphorylation sites for robust \u03b2-arrestin2 binding at the MOR revisited. Commun Biol., 7(1): 933.","DOI":"10.1038\/s42003-024-06571-1"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Xaviera A, Saleem A, Akhtar MF, Alshammari A and Albekairi NA (2024). Fumaric acid per se and in combination with methotrexate arrests inflammation via moderating inflammatory and oxidative stress biomarkers in arthritic rats. Immunopharmacol Immunotoxicol., 46(6): 793\u2013804.","DOI":"10.1080\/08923973.2024.2405171"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Xie M, Li D, Zeng H, Huang Y, Xu R, Wang Z, Yu J, Sun Y (2025). BAM8-22 targets spinal MrgC receptors to modulate UPRmt activity in the mechanism of bone cancer pain. Front Pharmacol., 16: 1575733.","DOI":"10.3389\/fphar.2025.1575733"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Xie F, Kitagawa Y, Ogata H, Yasuhara S, You Z and Jeevendra Martyn JA (2024). Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways. Cytokine., 183: 156737.","DOI":"10.1016\/j.cyto.2024.156737"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Yang L, Li M, Liu Y, Bai Y, Yin T, Chen Y, Jiang J, Liu S (2024). MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis. Acta Biochim Biophys Sin (Shanghai)., 56(9): 1323-1339.","DOI":"10.3724\/abbs.2024048"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Yu J, Li D, Xie M, Xie J, Wang Z, Gu X, Ma Z and Sun Y (2024). Complex topology of ubiquitin chains mediates lysosomal degradation of MrgC proteins. Cell Biochem Biophys., 82(2): 641\u2013645.","DOI":"10.1007\/s12013-023-01204-6"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhang F, Dong Y, Chen F, Niu M, Liu Z and Wang C (2024). Cinobufotalin capsule combined with zoledronic acid in the treatment of pain symptoms and clinical efficacy in prostate cancer patients with bone metastases: A retrospective study. Arch Esp Urol., 77(3): 242\u2013248.","DOI":"10.56434\/j.arch.esp.urol.20247703.32"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zhang H, Jiang J, Chen X, Zhu F, Fu F, Chen A, Fu L and Mao D (2024). Liu-Shen-Wan inhibits PI3K\/Akt and TRPV1 signaling alleviating bone cancer pain in rats. Cancer Biol Ther., 25(1): 2432098.","DOI":"10.1080\/15384047.2024.2432098"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Zhao J, Zhang Y, Lv S, Wang F, Shan T, Wang J, Liu Z, Zhang L, Cui H and Tian J (2025). Mechanism of formononetin in improving energy metabolism and alleviating neuronal injury in CIRI based on nontargeted metabolomics research. J Cell Mol Med., 29(4): e70340.","DOI":"10.1111\/jcmm.70340"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:07:30Z","timestamp":1788174450000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":24,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.8.233.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}